Company: STAA
Filing Date: 2025-08-05
Form Type: 8-K
Source: 0001193125-25-173090
Chunk: 5

Company: STAAR SURGICAL CO
Filing Date: 2025-08-05
Form: 8-K
Item: Item 9.01
Chunk 5
---
Item 9.01      Financial Statements and Exhibits  

(d) Exhibits

  Exhibit      Description of Exhibit                                                                                                                            
                                                                                                                                                                 
      No.                                                                                                                                                        
      2.1      Agreement and Plan of Merger, dated as of August 4, 2025, by and among STAAR Surgical Company, Alcon Research, LLC and Rascasse Merger Sub, Inc.  
     99.1      Joint press release of Alcon and the Company, dated August 5, 2025                                                                                
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive Data File (embedded within the Inline XBRL document)                                                                       

*   *   *

Additional Information About the Merger and Where to Find It

This report relates to the proposed transaction involving the Company. In connection with the proposed transaction, the Company will file relevant materials with the U. S. Securities and Exchange Commission (the “ SEC”), including the Company’s proxy statement on Schedule 14A (the “ Proxy Statement”). This report is not a substitute for the Proxy Statement or any other document that the Company may file with the SEC or send to its stockholders in connection with the proposed transaction. BEFORE MAKING ANY VOTING DECISION, STOCKHOLDERS OF THE COMPANY ARE URGED TO READ ALL RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC, INCLUDING THE PROXY STATEMENT, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS THERETO, IN CONNECTION WITH THE PROPOSED TRANSACTION WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. Investors and security holders will be able to obtain the documents (when available) free of charge at the SEC’s website, www. sec. gov, or by visiting the Company’s investor relations website, https://investors. staar. com.

No Offer or Solicitation

This report is for informational purposes only and is not intended to and does not constitute, or form part of, an offer, invitation or the solicitation of an offer or invitation to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any securities, or the solicitation of any vote or approval in any jurisdiction, pursuant to the proposed transaction or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law.